Skip to content

Oncologix Tech Inc.: 10-Q filed 2014-04-21

What Oncologix Tech Inc. reported in its quarterly report filed 2014-04-21 (fiscal Q2 2014): 27 published measures, 65 facts as tagged in accession 0001471242-14-000162.

This filing

Form
10-Q (quarterly report)
Filed
2014-04-21
Fiscal period
fiscal Q2 2014
Accession
0001471242-14-000162 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Oncologix Tech Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-02-282,318,578USD
At 2013-08-312,033,850USD
At 2013-02-282,033,850USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-02-282,841,189USD
At 2013-08-312,394,595USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-02-28-522,611USD
At 2013-08-31-360,745USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-02-2885,250USD
At 2013-08-3139,456USD
At 2013-02-2839,456USD
At 2012-08-311,931USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-09-01 to 2014-02-28-817,915USD181
2012-09-01 to 2013-02-28-100,666USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-09-01 to 2014-02-28-366,753USD181
2012-09-01 to 2013-02-28-47,748USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-09-01 to 2014-02-28-878USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-12-01 to 2014-02-28983,758USD90
2013-09-01 to 2014-02-281,708,391USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-09-01 to 2014-02-2867,232USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-02-28-47,876,266USD
At 2013-08-31-58,992,296USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-02-2848,232USD
At 2013-08-3178,533USD
At 2013-02-2878,533USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-09-01 to 2014-02-2891,163USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-12-01 to 2014-02-28-253,261USD90
2013-09-01 to 2014-02-28-305,998USD181
2012-12-01 to 2013-02-28-36,771USD90
2012-09-01 to 2013-02-28-80,575USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-02-28405,959USD
At 2013-08-31218,222USD
At 2013-02-28218,222USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-02-282,286,834USD
At 2013-08-311,583,095USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-02-281,781,779USD
At 2013-08-311,696,425USD
At 2013-02-281,696,425USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-12-01 to 2014-02-28488,423USD90
2013-09-01 to 2014-02-28771,237USD181
2012-12-01 to 2013-02-2836,771USD90
2012-09-01 to 2013-02-2880,575USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-12-01 to 2014-02-28235,162USD90
2013-09-01 to 2014-02-28465,239USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-12-01 to 2014-02-28748,596USD90
2013-09-01 to 2014-02-281,243,152USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-02-28103,260,511shares
At 2013-08-3174,587,422shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-02-2847,250,186USD
At 2013-08-3158,560,265USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-02-2819,999USD
At 2013-08-3111,820USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-02-2836,890USD
At 2013-08-3139,176USD
At 2013-02-2839,176USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-12-01 to 2014-02-28-684,832USD90
2013-09-01 to 2014-02-28-817,915USD181
2012-12-01 to 2013-02-28-53,725USD90
2012-09-01 to 2013-02-28-100,666USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-12-01 to 2014-02-28482,383USD90
2013-09-01 to 2014-02-28759,744USD181
2012-12-01 to 2013-02-2836,681USD90
2012-09-01 to 2013-02-2880,395USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-09-01 to 2014-02-2810,000USD181
2012-09-01 to 2013-02-2840,000USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-09-01 to 2014-02-28-144,229USD181

Inspect the source

Entity
Oncologix Tech Inc. / CIK 0000799694
Captured
SEC response SHA-256
acc83506e9d3f32d85d91503a2bd087a712fbc014fe7429b835fa6f76c6de48d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000799694.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))